Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.24 -0.06 (-4.58%)
As of: Sep 29, 2026 · 3:50 PM EDT

Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities (2023 - 2025)

Updated

Zhengye Biotechnology Holding's Total Current Liabilities was $16.99 million in the quarter ended Dec 31, 2025, down 10.2% from $18.92 million a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Total Current Liabilities at Zhengye Biotechnology Holding came in at $17.23 million, down 7.5% from the prior year.

  • In earlier years, Total Current Liabilities was $18.62 million in the year ended Dec 31, 2024 (-12.4%) and $21.26 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Zhengye Biotechnology Holding 61.61 Mn 48.99 Mn - 16.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 16.99 Mn
Jun 30, 2025 18.82 Mn
Dec 31, 2024 18.92 Mn
Dec 31, 2023 20.87 Mn
API Access

Zhengye Biotechnology Holding Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ZYBT&period=max&api_key=YOUR_API_KEY